News Center

Donaldson DCI 2025 Fiscal Year Data Release

According to publicly available information, the financial report of Donaldson Corporation (NYSE: DCI) for the fiscal year 2025 (July 1, 2024- June 30, 2025) is as follows:


Revenue and Profit

Total revenue: $3.7 billion, a historic high, with a year-on-year increase of approximately 2.2% ($3.62 billion in fiscal year 2024).

Adjusted earnings per share (EPS): $3.68, with a slight year-on-year increase.

Operating profit margin: 16.4% (adjusted), setting a historical record.

Net profit: not directly disclosed, but the cumulative net profit for the first three quarters was $253 million, a year-on-year decrease of 16.96%. It is speculated that the net profit for the whole year may rebound due to the optimization of operations in the fourth quarter.


Business sector performance

Mobile solutions (accounting for 60%):

Benefiting from the growing demand for alternative fuel technologies such as hydrogen and natural gas, we have maintained strong performance.

Industrial solutions (accounting for 30%):

By connecting products such as smart sensors, we can drive sales of after-sales components and achieve 3-4 times growth.

Life Sciences (8-10%):

Progress is slower than expected, mainly due to weak demand in the academic research field, resulting in a 5.4% decline in revenue (Q1 data) and a narrowing of gross profit margin to 52.3%.

The company still sees long-term opportunities and plans to accelerate its development through mergers and acquisitions and internal growth.


Regional market performance

The United States: The construction, mining, and agricultural markets are declining, while the industrial sector is performing steadily.

Europe: the most stable region with extensive growth in the after-sales market.

Latin America: The most challenging market with significant demand fluctuations.

Asia Pacific: There are slight signs of recovery in the Chinese market, but overall growth has slowed down.

‌

Operational efficiency and strategic adjustment


cost optimization

Through vertical business restructuring (such as closing two manufacturing factories), operational efficiency has been improved, resulting in a customer delivery rate of 95% (higher than pre pandemic levels).

After sales market revenue accounts for 68%, reflecting a high customer retention rate.


Technical investment

Having over 3000 patents and obtaining an average of one new patent per day, it has a significant technological advantage.

75% of products are produced in consumer regions, and global layout enhances supply chain resilience.


Medium and Long Term Strategy


Continuously investing in research and development and technological innovation, focusing on the leading position in filtration technology.

Priority funds are used for internal growth and mergers and acquisitions, especially in the field of life sciences.

The management emphasizes confidence in long-term growth and profit margin improvement.


Key Challenges and Responses


The life sciences department is dragging down: weak demand for academic research has led to a decline in revenue, and the company plans to reverse the situation through product innovation and market expansion.

Cost pressure: Optimize variable costs through vertical integration and factory closure to increase profit margins.

Regional risk: Latin American market volatility needs to be addressed through localized strategies.

‌

summary

Donaldson's overall performance in the fiscal year 2025 is robust, driven by growth in the mobile and industrial sectors, but the life sciences sector faces short-term challenges. The company maintains profit margins through technological investment and cost optimization, and actively lays out long-term strategies. It is recommended to track the full release of financial reports through official channels to obtain more detailed financial data and analysis.

Copyright © 2025 Jiangsu HaanYo Intelligent Technology Co., Ltd. All rights reserved